ANALYST-UPGRADE ·Filed Jul 9, 2026

SYK

STRYKER CORP
BULLISH
Impact 3/10
Processed2mo ago SECanalyst-SYK-bmocapit-20260709
BMO Capital initiates coverage on SYK at Outperform
Actionable Insight ▲ Bullish

With earnings 20 days away, the high short ratio creates a potential squeeze setup. The bullish initiation from BMO, while conservative on price, adds to the positive chorus. Traders should watch for a beat-and-raise that could trigger a short-covering rally, but the insider sales warrant caution on position size.

DirectionBullish
Final — all horizons settled through T+60d
SYK ▼ -15.80% at T+60d
LONG call ✗ call lost -15.80% · α vs SPY -17.43% · entry $327.11 → $275.43
Entry anchored
Jul 9, 10:11 AM ET
via exchange tick
T+1d
+0.82%
call +0.82% · α +0.39%
$329.78
settled 3mo ago
T+5d
+1.25%
call +1.25% · α +1.38%
$331.20
settled 3mo ago
T+20d
+3.15%
call +3.15% · α +0.91%
$337.43
settled 8w ago
T+60d
-15.80%
call -15.80% · α -17.43%
$275.43
settled 9h ago

Price Chart

Loading chart...

Executive Summary

BMO Capital initiated coverage on Stryker Corp (SYK) at Outperform with a $369 price target, representing 12.9% upside from the current $326.85. The firm’s 53% accuracy on 1,842 rated calls places it near the middle of the analyst pack, but the call aligns with a strongly bullish consensus. The Street is 77% Buy-rated (27 of 35 analysts), with a mean target of $386.60 and median of $385.00. Current price implies 18.3% upside to the mean, so BMO’s target is more conservative than the average. Momentum is positive: 1 upgrade, 0 downgrades in the past 30 days, and EPS revisions for the current fiscal year show a slight upward tilt (2 up, 1 down). Insider selling by an executive (Robert Fletcher, ~$1.3M on May 28) provides a mild contrarian signal, partially offset by a congressional buy in April. The next earnings report is due July 29, 2026, within 20 days, adding a near-term catalyst. The high short-interest ratio of 76.2% could amplify any post-earnings move. Bottom line: BMO’s initiation adds a new bullish voice, but its below-consensus target and recent insider sales warrant a measured approach.

Impact Score

Base Score
2/7
LLM Adjustment
+1
Final Score
3/10

Consensus & Targets

Buy / Strong Buy
27 (77%)
Hold
8
Sell / Strong Sell
0
Total Analysts
25
Mean PT
$386.60
Median PT
$385.00
High PT
$465.00
Low PT
$315.00
Current Price
$326.85
Implied Upside
+18.3%

Of 35 analysts covering SYK, 13 are Strong Buy, 14 are Buy, and 8 are Hold — 77% Buy-rated. No Sell or Strong Sell ratings. The consensus is overwhelmingly bullish and has been directionally stable for months.

Mean PT is $386.60, median $385.00, high $465.00, low $315.00. Current price of $326.85 implies 18.3% upside to the mean. BMO’s $369 target sits 4.5% below the mean and 4.2% below the median, making it one of the more conservative bullish calls.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-07-09BMO CapitalinitiateOutperform$369.00
2026-07-06Evercore ISI GroupmaintainOutperform—
2026-06-05Leerink PartnersmaintainOutperform$407.00
2026-05-04Truist SecuritiesreiterateHold$330.00
2026-05-04BarclaysmaintainOverweight$394.00
2026-05-01Canaccord GenuitymaintainBuy$400.00
2026-05-01JP MorganmaintainOverweight$400.00
2026-05-01Evercore ISI GroupmaintainOutperform$355.00
2026-05-01Wells FargomaintainOverweight$418.00
2026-05-01NeedhammaintainBuy$418.00

30-day activity: 1 upgrade (the initiation), 0 downgrades. EPS revisions show a mixed but slightly positive trend: current fiscal year EPS had 2 upward revisions and 1 downward in the last 30 days, while next fiscal year had 1 up and 2 down. Estimates are broadly stable.

Firm Track Record — BMO Capital

BMO Capital accuracy: 53% on 1842 calls | avg return: 2.3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Piper Sandler100%3/34.8%top tier
Roth MKM100%2/20.9%top tier
UBS100%3/36.2%top tier
Baird100%2/24.7%top tier
BTIG89%8/94.6%top tier
JMP Securities67%2/30%top tier
Stifel67%2/32%top tier
Truist Securities64%7/111.3%top tier
Evercore ISI Group63%5/81.4%top tier
Barclays60%3/52.4%above average

BMO Capital has a 53% accuracy rate on 1,842 scored calls with an average return of 2.3%. Among firms covering SYK, the top performers are Piper Sandler (100% on 3 calls), UBS (100% on 3, avg return 6.2%), and BTIG (89% on 9, avg return 4.6%). BMO’s accuracy is below those top-tier shops but still solid given its large sample size.

Earnings Estimates

Next earnings: Jul 29, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$3.49$3.36 — $3.61$6.6B↑0 ↓0
+1q$3.68$3.00 — $3.81$6.7B↑0 ↓0
0y$14.98$14.86 — $15.08$27.3B↑0 ↓0
+1y$16.72$16.43 — $16.96$29.6B↑0 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 5 sells
Congressional
Ro Khanna (democrat) — buy $15,001 - $50,000
Institutional
Assenagon Asset Management S.A. — doubled (263%)
Institutional
Empowered Funds, LLC — add (92.4%)
Institutional
Walleye Capital LLC — near_exit (-81.2%)
Short Interest
Short: 808,158 | Exempt: 1,224 | TRF Vol: 1,060,717 | Short Ratio: 76.2% | Off-exchange volume (dark pool + OTC)

Insider trades: Robert Fletcher sold a total of ~$1.3M in SYK on May 28, 2026. While the cluster is large, the single-date pattern suggests a planned sale, reducing its bearish signal. Congressional activity: Rep. Ro Khanna bought $15k–$50k in April 2026 (bullish, but small). Institutional flows: Wellington Management added 25.1% ($2.67B position), Assenagon doubled (+263%), and Empowered Funds added 92.4%. Conversely, Norges Bank exited and Walleye Capital reduced 81.2%. Short interest is 76.2% of off-exchange volume, indicating elevated bearish positioning. The analyst signal (bullish) converges with institutional buying but diverges from insider selling and high short interest.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

Report based on filing metadata.

16 reports for SYK
Performance horizon
71% Hit rate 5 of 7 directional calls best @ T+20▲ +9.98%Jun 17, 2026
Filters
Rows
Reports for SYK — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$317.40 $275.39▼ −13.24%▼ −13.55%$275.43 (−13.22%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$329.67 $274.19▼ −16.83%▼ −18.03%$275.43 (−16.45%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$327.70 $280.13▼ −14.52%▼ −14.52%$275.43 (−15.95%)
Jul 13, 2026
11w ago
Court Ruling
BULLISH ★ 6/10
$331.45 $345.81▲ +4.33%▲ +1.15%$275.43 (−16.90%)
Jul 9, 2026
12w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$327.11 $337.43▲ +3.15%▲ +0.91%$275.43 (−15.80%)
Jun 26, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$332.71 $318.97▼ −4.13%▼ −5.39%$275.43 (−17.22%)
Jun 17, 2026
15w ago
Court Ruling
BULLISH ★ 6/10
$301.14 $331.20▲ +9.98%▲ +8.66%$275.43 (−8.54%)
May 29, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$299.24 $330.52▲ +10.45%▲ +12.77%$275.43 (−7.96%)
May 29, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$299.24 $330.52▲ +10.45%▲ +12.77%$275.43 (−7.96%)
Apr 30, 2026
22w ago
Press Release
BEARISH ★ 8/10
$293.78 $299.24▼ −1.86%▲ +3.41%$275.43 (+6.24%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (64h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 9, 2026